Gabapentin Pediatric Dosing
For pediatric patients ages 3-11 years with epilepsy, start gabapentin at 10-15 mg/kg/day divided three times daily, then titrate over 3 days to a maintenance dose of 25-35 mg/kg/day (ages 5-11) or 40 mg/kg/day (ages 3-4), with doses up to 50 mg/kg/day well-tolerated in long-term studies. 1
Age-Specific Dosing Guidelines
Children 3-11 Years (FDA-Approved for Epilepsy)
The FDA label provides clear weight-based dosing 1:
- Starting dose: 10-15 mg/kg/day divided into three doses
- Titration period: Approximately 3 days to reach maintenance dose
- Maintenance doses:
- Ages 3-4 years: 40 mg/kg/day in three divided doses
- Ages 5-11 years: 25-35 mg/kg/day in three divided doses
- Maximum studied dose: 50 mg/kg/day (well-tolerated in long-term studies)
- Dosing interval: Maximum 12 hours between doses
Adolescents ≥12 Years
Use adult dosing 1:
- Starting: 300 mg three times daily
- Maintenance: 300-600 mg three times daily
- Maximum: 3600 mg/day (though 1800 mg/day often sufficient)
Infants <1 Year (Off-Label)
Recent research supports gabapentin use in infants, though this remains off-label 2, 3:
- Starting dose: 5-10 mg/kg/day, typically given every 24 hours initially
- Titration: Gradual increase based on response
- Maximum doses studied: Up to 25.5 mg/kg/day
- Common indications: Irritability, neuropathic pain, rescue sedation
Important caveat: Clearance is highly variable in infants <1 year, requiring careful individualization 1. Start conservatively at 5 mg/kg/dose every 24 hours 2.
Special Populations
Renal Impairment
Gabapentin is renally cleared and requires dose adjustment 1, 4:
For children ≥12 years, use the adult renal dosing table. For younger children with renal impairment:
- Mild RI: Reduce to twice daily dosing
- Moderate RI: Reduce to once daily dosing
- Severe RI: Once daily with 50% dose reduction, or every other day dosing 4
Critical point: Pediatric patients <12 years with renal impairment have not been formally studied in FDA trials 1, but recent PBPK modeling suggests AUC increases 2.09-fold (mild), 3.30-fold (moderate), and 31.67-fold (severe RI) 4.
Children with Severe Neurological Impairment
For chronic pain management in nonverbal children with CNS impairment 5:
- Children ≤5 years: Mean effective dose 50 mg/kg/day (95% CI: 45-56)
- Children >11 years: Mean effective dose 36 mg/kg/day (95% CI: 34-38)
- Response rate: 91% showed >50% reduction in pain behaviors
Practical Titration Strategy
Step-by-step approach:
- Week 1: Start at 10-15 mg/kg/day divided TID
- Day 3-4: Assess tolerance; if well-tolerated, increase to target maintenance
- Target maintenance (by end of week 1):
- Ages 3-4: 40 mg/kg/day TID
- Ages 5-11: 25-35 mg/kg/day TID
- Ages ≥12: 900-1800 mg/day TID
- Further titration: If needed, can increase up to 50 mg/kg/day in younger children or 3600 mg/day in adolescents
Faster titration is possible: Research shows gabapentin can be initiated at 900 mg/day in adolescents and rapidly titrated to 3600 mg/day with good tolerance 6, though the FDA label recommends more gradual increases 1.
Common Pitfalls
- Underdosing: Many clinicians use 1800 mg/day in adolescents when 3600 mg/day may be more effective 6
- Inadequate trial duration: Allow 3-8 weeks for titration plus 2 weeks at maximum dose before declaring treatment failure 7
- Missing renal impairment: Always assess renal function before dosing, as clearance is directly proportional to creatinine clearance 1
- Abrupt discontinuation: Taper over minimum 1 week when stopping 1
Tolerability
Gabapentin is generally well-tolerated in pediatrics 1, 2, 3:
- Common side effects: Dose-dependent dizziness and sedation (usually transient)
- Serious adverse events: Rare in pediatric studies
- Drug interactions: Minimal, as gabapentin is not metabolized 1